Antimicrobial resistance is a global public health concern that is impacted by both human
and non-human antimicrobial use. It is therefore essential to prevent and control emerging
antimicrobial resistance problems in a coordinated manner in agriculture, human and
veterinary medicine. The consequences of antimicrobial resistance are particularly
important when disease is caused by pathogens that are resistant to antimicrobials
considered critically important in the treatment of human disease by the World Health
WHO convened the first meeting of the Advisory Group on Integrated Surveillance of
Antimicrobial Resistance (AGISAR) in Copenhagen, Denmark on 15-19 June 2009. At
this meeting, participants reviewed the criteria.
During the first part of the consultation, the experts adapted the WHO list of CIA
developed in Canberra in 2005 and reviewed in Copenhagen in 2007. The AGISAR
participants felt the criteria were appropriate; minor changes were made for sake of clarity
of the text describing the criteria and greater explanation were given in the text
accompanying the list..